These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1388 related items for PubMed ID: 18951217

  • 21. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.
    Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Kapp DS.
    Br J Cancer; 2007 Jun 18; 96(12):1817-22. PubMed ID: 17519907
    [Abstract] [Full Text] [Related]

  • 22. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
    Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, Tamussino K, Winter R, Pellegrino A, Greggi S, Angioli R, Manci N, Scambia G, Dell'Anna T, Fossati R, Floriani I, Rossi RS, Grassi R, Favalli G, Raspagliesi F, Giannarelli D, Martella L, Mangioni C.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):560-6. PubMed ID: 15840878
    [Abstract] [Full Text] [Related]

  • 23. Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study.
    Gadducci A, Zola P, Landoni F, Maggino T, Sartori E, Bergamino T, Cristofani R.
    Gynecol Oncol; 1995 Jul 20; 58(1):42-7. PubMed ID: 7789889
    [Abstract] [Full Text] [Related]

  • 24. Nadir CA-125 level is an independent prognostic factor in advanced epithelial ovarian cancer.
    Kang S, Seo SS, Park SY.
    J Surg Oncol; 2009 Sep 01; 100(3):244-7. PubMed ID: 19267361
    [Abstract] [Full Text] [Related]

  • 25. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 1999 Feb 01; 8(2):129-37. PubMed ID: 10067810
    [Abstract] [Full Text] [Related]

  • 26. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
    Osman N, O'Leary N, Mulcahy E, Barrett N, Wallis F, Hickey K, Gupta R.
    Ir Med J; 2008 Sep 01; 101(8):245-7. PubMed ID: 18990955
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study.
    Kang S, Kang WD, Chung HH, Jeong DH, Seo SS, Lee JM, Lee JK, Kim JW, Kim SM, Park SY, Kim KT.
    J Clin Oncol; 2012 Apr 20; 30(12):1329-34. PubMed ID: 22412131
    [Abstract] [Full Text] [Related]

  • 32. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC.
    Hepatogastroenterology; 2005 Apr 20; 52(66):1688-91. PubMed ID: 16334758
    [Abstract] [Full Text] [Related]

  • 33. Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.
    Espín F, Bianchi A, Llorca S, Feliu J, Palomera E, García O, Remon J, Suñol X.
    Eur J Surg Oncol; 2012 Jun 20; 38(6):497-502. PubMed ID: 22445061
    [Abstract] [Full Text] [Related]

  • 34. [Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma].
    Lan CY, Huang H, Liu JH.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct 20; 43(10):732-6. PubMed ID: 19087537
    [Abstract] [Full Text] [Related]

  • 35. Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma.
    Geisler JP, Miller GA, Lee TH, Harwood RM, Wiemann MC, Geisler HE.
    J Reprod Med; 1996 Mar 20; 41(3):140-2. PubMed ID: 8778409
    [Abstract] [Full Text] [Related]

  • 36. The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer.
    Høgdall CK, Nørgaard-Pedersen B, Mogensen O.
    Anticancer Res; 2002 Mar 20; 22(3):1765-8. PubMed ID: 12168866
    [Abstract] [Full Text] [Related]

  • 37. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
    Wu M, Shen K, Lang J.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr 20; 35(4):200-3. PubMed ID: 11776158
    [Abstract] [Full Text] [Related]

  • 38. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis.
    Tsai CC, Liu YS, Huang EY, Huang SC, Chang HW, Tseng CW, ChangChien CC.
    Gynecol Oncol; 2006 Mar 20; 100(3):591-5. PubMed ID: 16290001
    [Abstract] [Full Text] [Related]

  • 39. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.
    Paramasivam S, Tripcony L, Crandon A, Quinn M, Hammond I, Marsden D, Proietto A, Davy M, Carter J, Nicklin J, Perrin L, Obermair A.
    J Clin Oncol; 2005 Sep 01; 23(25):5938-42. PubMed ID: 16087942
    [Abstract] [Full Text] [Related]

  • 40. [Cytoreductive surgery in the management of stage IV epithelial ovarian cancer].
    Zang R, Zhang Z, Chen J.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr 01; 35(4):197-9. PubMed ID: 11776157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 70.